| Item | Cat. No. | Application | Isotype | 
| Anti-CD47/CD274 mAbs [Amostomig Biosimilar] (MABL-4377) | MABL-4377 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Lambda | 
| Anti-F11 mAbs [Amrecibart Biosimilar] (MABL-4378) | MABL-4378 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa | 
| Anti-SARS-CoV-2 Spike RBD mAbs [Amubarvimab Biosimilar] (MABL-4379) | MABL-4379 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-MS4A1/CD20 mAbs [Amulirafusp Biosimilar] (MABL-4380) | MABL-4380 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-ERBB2/CD340/HER2 (Domain II);ERBB2/CD340/HER2 (Domain IV) mAbs [Anbenitamab Biosimilar] (MABL-4 | MABL-4381 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa | 
| Anti-MUC16/CA125 mAbs [Abagovomab Biosimilar] (MABL-4337) | MABL-4337 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-PDCD1/CD279/PD1 mAbs [Abazistobart Biosimilar] (MABL-4338) | MABL-4338 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa | 
| Anti-ITGA2B/CD41 mAbs [Abciximab Biosimilar] (MABL-4339) | MABL-4339 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-F11 mAbs [Abelacimab Biosimilar] (MABL-4340) | MABL-4340 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda | 
| Anti-TNFRSF5/CD40 mAbs [Abiprubart Biosimilar] (MABL-4341) | MABL-4341 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa | 
| Anti-ITGAV/CD51 mAbs [Abituzumab Biosimilar] (MABL-4342) | MABL-4342 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa | 
| Anti-IL13 mAbs [Abrezekimab Biosimilar] (MABL-4343) | MABL-4343 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-ITGA4B7 mAbs [Abrilumab Biosimilar] (MABL-4344) | MABL-4344 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa | 
| Anti-FOLH1/GCPII/PSMA;CD3E mAbs [Acapatamab Biosimilar] (MABL-4345) | MABL-4345 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda | 
| Anti-PDL1/CD274 mAbs [Acasunlimab Biosimilar] (MABL-4346) | MABL-4346 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Kappa | 
| Anti-FCGR3A mAbs [Acimtamig Biosimilar] (MABL-4347) | MABL-4347 | ELISA, FACS, Functional assay, in vivo binding | na;na, Lambda;Kappa | 
| Anti-PDCD1/CD279/PD1 mAbs [Acrixolimab Biosimilar] (MABL-4348) | MABL-4348 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa | 
| Anti-Clostridium difficile Toxin A mAbs [Actoxumab Biosimilar] (MABL-4349) | MABL-4349 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-CXCL8 mAbs [Adakitug Biosimilar] (MABL-4350) | MABL-4350 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
| Anti-TNF/TNFA mAbs [Adalimumab Biosimilar] (MABL-4351) | MABL-4351 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa | 
      联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
